Abstract
Objective
To analyze the clinical characteristics of familial nonmedullary thyroid carcinoma (FNMTC), in order to provide evidence for early diagnosis and treatment.
Methods
We retrospectively investigated the inpatients between September 2006 and September 2013 in the First Bethune Hospital of Jilin University, in which 78 patients with FNMTC from 31 families were analyzed by a comparison with 3445 control cases from the patients with sporadic nonmedullary thyroid carcinoma (SNMTC).
Results
There was no significant difference in gender, age, and tumor size between FNMTC and SNMTC patients. However, the characteristics of disease in multifoci, neck lymph node metastasis, invasion to the surrounding tissues, and coexistence with Hashimoto disease in two types of cancer patients show significant difference. They are: multifoci: 71.8 % (56/78) in FNMTC versus 46.3 % (1595/3445) in SNMTC; neck lymph node metastasis: 52.6 % (41/78) in FNMTC versus 33.3 % (1148/3445) in SNMTC; surrounding tissue invasion: 64.1 % (50/78) in FNMTC versus 48.5 % (1670/3445) in SNMTC; coexistence with Hashimoto disease: 30.8 % (24/78) in FNMTC versus 20.0 % (689/3445) in SNMTC.
Conclusion
Lymph node metastasis, multifoci, invasion to the surrounding tissues, and combination with chronic lymphocytic thyroiditis are the main features of FNMTC, which suggests the extent of the operation for FNMTC patients should be amplified properly.
Similar content being viewed by others
References
Sturgeon C, Clark OH (2005) Familial nonmedullary thyroid cancer. Thyroid 15(6):588–593
Xing MZ (2005) The T1799A BRAF mutation is not a germline mutation in familial nonmedullary thyroid cancer. Clin Endocrinol 63(3):263–266
Alsanea O, Clark OH (2001) Familial thyroid cancer. Curr Opin Oncol 13(1):44–51
Park YJ, Ahn HY, Choi HS et al (2012) The long-term outcomes of the second generation of familial nonmedullary thyroid carcinoma are more aggressive than sporadic cases. Thyroid 22(4):356–362
Mazeh H, Benavidez J, Poehls JL et al (2012) In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease. Thyroid 22(1):3–8
Moses W, Weng J, Kebebew E (2011) Prevalence, clinicopathologic features, and somatic genetic mutation profile in familial versus sporadic nonmedullary thyroid cancer. Thyroid 21(4):367–371
Uchino S, Noguchi S, Kawamoto H et al (2002) Familial nonmedullary thyroid carcinoma characterized by multifocality and a high recurrence rate in a large study population. World J Surg 26(8):897–902. doi:10.1007/s00268-002-6615-y
Capezzone M, Marchisotta S, Cantara S et al (2008) Familial non-medullary thyroid carcinoma displays the features of clinical anticipation suggestive of a distinct biological entity. Endocr Relat Cancer 15:1075–1081
Zhao J, Yu Y, Xia TT et al (2011) Biological characteristics and treatment of familial thyroid carcinoma. Chin J Otorhinolaryngol Head Neck Surg 46(11):897–900
Sippel RS, Caron NR, Clark OH (2007) An evidence-based approach to familial nonmedullary thyroid cancer: screening, clinical management, and follow-up. World J Surg 31:924–933. doi:10.1007/s00268-006-0847-1
McDonald TJ, Driedger AA, Garcia BM et al (2011) Familial papillary thyroid carcinoma: a retrospective analysis. J Oncol 2011:948786
Robenshtok E, Tzvetov G, Grozinsky-Glasberg S et al (2011) Clinical characteristics and outcome of familial nonmedullary thyroid cancer: a retrospective controlled study. Thyroid 21:43–48
Huang RP, Song CF, Dai WJ (2007) Development of treatment for familial thyroid carcinoma. Chin J Pract Surg 27(9):750–752
Author information
Authors and Affiliations
Corresponding author
Additional information
Zhang Qiang and Yang Shuai are the co-first authors.
Rights and permissions
About this article
Cite this article
Zhang, Q., Yang, S., Meng, Xy. et al. Clinical Analysis of Familial Nonmedullary Thyroid Carcinoma. World J Surg 40, 570–573 (2016). https://doi.org/10.1007/s00268-015-3342-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00268-015-3342-8